Skip to main content

Advertisement

Table 3 Interventions ranking the treatments names column follow the league table (which arranges the presentation of summary estimates by ranking the treatments in order of most pronounced impact on the outcome under consideration) the numerical values represents the cumulative results of the probability of being best in which the highest score is 1 or 100% (see Rankogram)

From: Effectiveness of contrast-associated acute kidney injury prevention methods; a systematic review and network meta-analysis

Treatment SUCRA Treatment SUCRA
Allopurinol 0.9647 NaHCO3 0.3419
MESNA 0.9427 Pentoxifylline 0.3391
PGE1 0.7809 I.V Hydration 0.3124
α-tocopherol 0.7614 Placebo 0.2694
Oxygen 0.7527 Oral Hydration 0.2517
K/Na citrate 0.7469 Hypothermia 0.2021
Trimetazidine 0.7151 Control 0.1658
Probucol 0.7042 Amlodipine and Valsartan 0.05485
γ-tocopherol 0.689 ACEI 0.5783
BNP 0.6767 Aminophylline 0.6593
Anisodamine 0.6594 Iloprost 0.7481
Nicorandil 0.6442 Acetazolamide 0.6242
Theophylline 0.629 ANP 0.3291
RIPC 0.5692 Zinc 0.198
Statins 0.5497 Dialysis 0.4319
MgSO4 0.5177 Fenoldopam 0.2296
NAC 0.4592 ERAs 0.06734
Nebivolol 0.4543 CCB 0.7249
Ascorbic Acid 0.4433 Dopamine 0.1916
Alpha-Lipoic Acid 0.4322 Mannitol 0.1905
Furosemide 0.4027 Cordyceps 0.4459
Glutathione 0.3554 Silymarin 0.7934
Analysis Random Effects (Vague)